The antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: in vitro and in vivo evaluation

QR Code

The antitumor activity of a doxorubicin loaded, iRGD-modified sterically-stabilized liposome on B16-F10 melanoma cells: in vitro and in vivo evaluation

Ke-Fu Yu,1 Wei-Qiang Zhang,1 Li-Min Luo,1 Ping Song,1 Dan Li,1 Ruo Du,1 Wei Ren,1 Dan Huang,1 Wan-Liang Lu,1,2 Xuan Zhang,1 Qiang Zhang1,2 1Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, People’s Republic of China; 2State Key Laboratory of Natur...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Yu KF, Zhang WQ, Luo LM, Song P, Li D, Du R, Ren W, Huang D, Lu WL, Zhang X, Zhang Q
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2013
Sujets:	Medicine (General) R5-920
Accès en ligne:	https://doaj.org/article/4098baa5e2bd4b20877db981e6c8a54c
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Antitumor effect of iRGD-modified liposomes containing conjugated linoleic acid–paclitaxel (CLA-PTX) on B16-F10 melanoma
par: Du R, et autres
Publié: (2014)

Antitumor Activity of Thermosensitive Hydrogels Packaging Gambogic Acid Nanoparticles and Tumor-Penetrating Peptide iRGD Against Gastric Cancer
par: Zhang D, et autres
Publié: (2020)

Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment
par: Zhang Z, et autres
Publié: (2018)

The antitumor activity of tumor-homing peptide-modified thermosensitive liposomes containing doxorubicin on MCF-7/ADR: in vitro and in vivo
par: Wang C, et autres
Publié: (2015)

Remarkable Boron Delivery Of iRGD-Modified Polymeric Nanoparticles For Boron Neutron Capture Therapy
par: Chen J, et autres
Publié: (2019)

Effective Triple-Negative Breast Cancer Targeted Treatment Using iRGD-Modified RBC Membrane-Camouflaged Nanoparticles
par: Huang J, et autres
Publié: (2021)

iRGD Peptide-Mediated Liposomal Nanoparticles with Photoacoustic/Ultrasound Dual-Modality Imaging for Precision Theranostics Against Hepatocellular Carcinoma
par: Li H, et autres
Publié: (2021)

sTRAIL-iRGD is a promising therapeutic agent for gastric cancer treatment
par: Ying Huang, et autres
Publié: (2017)

iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancer
par: Naiqing Ding, et autres
Publié: (2019)

Synovitis in mice with inflammatory arthritis monitored with quantitative analysis of dynamic contrast-enhanced NIR fluorescence imaging using iRGD-targeted liposomes as fluorescence probes
par: Wu H, et autres
Publié: (2018)

The co-delivery of a low-dose P-glycoprotein inhibitor with doxorubicin sterically stabilized liposomes against breast cancer with low P-glycoprotein expression
par: Gao W, et autres
Publié: (2014)

iRGD-modified lipid–polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability
par: Gao F, et autres
Publié: (2017)

Short-time focused ultrasound hyperthermia enhances liposomal doxorubicin delivery and antitumor efficacy for brain metastasis of breast cancer
par: Wu SK, et autres
Publié: (2014)

iRGD‐modified exosomes effectively deliver CPT1A siRNA to colon cancer cells, reversing oxaliplatin resistance by regulating fatty acid oxidation
par: Dan Lin, et autres
Publié: (2021)

Synergistic effect of cold atmospheric pressure plasma and free or liposomal doxorubicin on melanoma cells
par: Konstantina Pefani-Antimisiari, et autres
Publié: (2021)

Co-Administration of iRGD with Sorafenib-Loaded Iron-Based Metal-Organic Framework as a Targeted Ferroptosis Agent for Liver Cancer Therapy
par: Liu X, et autres
Publié: (2021)

Co-Administration Of iRGD Enhances Tumor-Targeted Delivery And Anti-Tumor Effects Of Paclitaxel-Loaded PLGA Nanoparticles For Colorectal Cancer Treatment
par: Zhong Y, et autres
Publié: (2019)

Treatment of neuroblastoma and rhabdomyosarcoma using RGD-modified liposomal formulations of patupilone (EPO906)
par: Scherzinger-Laude K, et autres
Publié: (2013)

Enhanced antitumor efficacy of doxorubicin-encapsulated halloysite nanotubes
par: Li K, et autres
Publié: (2017)

Influence of PEGylation and RGD loading on the targeting properties of radiolabeled liposomal nanoparticles
par: Rangger C, et autres
Publié: (2012)

Coadministration of doxorubicin and etoposide loaded in camel milk phospholipids liposomes showed increased antitumor activity in a murine model
par: Maswadeh HM, et autres
Publié: (2015)

Galactose Modified Liposomes for Effective Co-Delivery of Doxorubicin and Combretastatin A4
par: Lian B, et autres
Publié: (2021)

Lactosylated liposomes for targeted delivery of doxorubicin to hepatocellular carcinoma
par: Zhou X, et autres
Publié: (2012)

Enhanced anticancer efficacy of paclitaxel through multistage tumor-targeting liposomes modified with RGD and KLA peptides
par: Sun J, et autres
Publié: (2017)

Cyclic RGD peptide-modified liposomal drug delivery system for targeted oral apatinib administration: enhanced cellular uptake and improved therapeutic effects
par: Song Z, et autres
Publié: (2017)

Antitumor Effect of Hyperoside Loaded in Charge Reversed and Mitochondria-Targeted Liposomes
par: Feng Y, et autres
Publié: (2021)

Novel RGD-lipid conjugate-modified liposomes for enhancing siRNA delivery in human retinal pigment epithelial cells
par: Chen CW, et autres
Publié: (2011)

Cyclic RGD peptide-modified liposomal drug delivery system: enhanced cellular uptake in vitro and improved pharmacokinetics in rats
par: Chen Z, et autres
Publié: (2012)

Liposomal n-butylidenephthalide protects the drug from oxidation and enhances its antitumor effects in glioblastoma multiforme
par: Lin YL, et autres
Publié: (2015)

The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models
par: Naiara Martínez-Vélez, et autres
Publié: (2019)

Pd(OAc)2-catalyzed asymmetric hydrogenation of sterically hindered N-tosylimines
par: Jianzhong Chen, et autres
Publié: (2018)

Potential antitumor activity of novel DODAC/PHO-S liposomes
par: Luna ACL, et autres
Publié: (2016)

Lactoferrin-modified PEGylated liposomes loaded with doxorubicin for targeting delivery to hepatocellular carcinoma
par: Wei MY, et autres
Publié: (2015)

Noninvasive Molecular Imaging of the Enhanced Permeability and Retention Effect by 64Cu-Liposomes: In vivo Correlations with 68Ga-RGD, Fluid Pressure, Diffusivity and 18F-FDG
par: Børresen B, et autres
Publié: (2020)

Oleanolic acid liposomes with polyethylene glycol modification: promising antitumor drug delivery
par: Gao D, et autres
Publié: (2012)

Acute and long-term effects of hyperthermia in B16-F10 melanoma cells.
par: Mónica Pereira Garcia, et autres
Publié: (2012)

Tumor Microenvironmental Responsive Liposomes Simultaneously Encapsulating Biological and Chemotherapeutic Drugs for Enhancing Antitumor Efficacy of NSCLC
par: Kong L, et autres
Publié: (2020)

Dual actions of albumin packaging and tumor targeting enhance the antitumor efficacy and reduce the cardiotoxicity of doxorubicin in vivo
par: Zheng K, et autres
Publié: (2015)

Anticancer and cardio-protective effects of liposomal doxorubicin in the treatment of breast cancer
par: Franco YL, et autres
Publié: (2018)

Antitumor activity of a folate receptor-targeted immunoglobulin G-doxorubicin conjugate
par: Yang T, et autres
Publié: (2017)